Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
DUBAI, United Arab Emirates, Jan. 10, 2026 (GLOBE NEWSWIRE) -- Security reviews have become one of the most important steps for decentralized lending protocols. Mutuum Finance (MUTM) confirmed that...
-
DUBAI, United Arab Emirates, Jan. 10, 2026 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM), a new crypto project building a decentralized lending and borrowing protocol, has provided an update on its...
-
DUBAI, United Arab Emirates, Jan. 10, 2026 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM), a decentralized, non-custodial lending and borrowing protocol under development, has announced the completion of...
-
COPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and strategic roadmap update, including planned 2026 key corporate milestones....
-
ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of the IPACE-HIV study.
-
SAN DIEGO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today provided...
-
MONTRÉAL, 09 janv. 2026 (GLOBE NEWSWIRE) -- Ressources Cerro de Pasco est heureuse de présenter un rapport opérationnel et une mise à jour de ses activités, mettant en évidence les principaux...
-
MONTREAL, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Cerro de Pasco Resources Inc. (TSXV CDPR) (OTCQB GPPRF) (FRA N8HP) (the Company or CDPR) is pleased to provide an operational review and corporate update...
-
- PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy for intermediate-risk NMIBC now expected in 1H 2026, nearly one year ahead of schedule - First randomized registrational trial...
-
Following Guidance from the European Medicines Agency’s (EMA) Scientific Advice Working Party (SAWP) Regarding Iopofosine I 131 for the Treatment of Waldenstrom’s Macroglobulinemia (WM), Expects to...